Warfarin-induced artery calcification is accelerated by growth and vitamin D

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 2, 2000, Pages 317-327

  Price, Paul A ^a   Faus, Samuel A ^a   Williamson, Matthew K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Artery calcification; Matrix Gla protein; Vitamin D; Vitamin K; Warfarin

Indexed keywords

4 CARBOXYGLUTAMIC ACID; ANTIVITAMIN K; CALCIUM; PHOSPHATE; VITAMIN D; VITAMIN K GROUP; WARFARIN;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CALCIFICATION; ARTICLE; CALCIUM BLOOD LEVEL; CHEMICAL ANALYSIS; CONTROLLED STUDY; DIET RESTRICTION; DISEASE PREDISPOSITION; GROWTH; MALE; NONHUMAN; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT;

EID: 0033967157     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.2.317     Document Type: Article

References (53)

1. Price PA, Urist MR, Otawara Y. Matrix Gla protein, a new γ-carboxyglutamic acid-containing protein which is associated with the organic matrix of bone. Biochem Biophys Res Commun. 1983;117: 765-771.
2. Price PA, Williamson MK. Primary structure of bovine matrix Gla protein, a new vitamin K-dependent bone protein. J Biol Chem. 1985; 260:14971-14975.
3. Fraser JD, Price PA. Lung, heart, and kidney express high levels of mRNA for the vitamin K-dependent matrix Gla protein: implications for the possible functions of matrix Gla protein and for the tissue distribution of the γ-carboxylase. J Biol Chem. 1988;263:11033-11036.
4. Hale JE, Fraser JD, Price PA. The identification of matrix Gla protein in cartilage. J Biol Chem. 1988;263:5820-5824.
5. 3 stimulates the synthesis of matrix γ-carboxyglutamic acid protein by osteosarcoma cells. J Biol Chem. 1988;263:911-916.
6. Shanahan CM, Weissberg PL, Metcalfe JC. Isolation of gene markers of differentiated and proliferating vascular smooth muscle cells. Circ Res. 1993;73:193-204.
7. Rannels SR, Cancela ML, Wolpert EB, Price PA. Matrix Gla protein mRNA expression in cultured type II pneumocytes. Am J Physiol. 1993; 265:L270-L278.
8. Cancela ML, Price PA. Retinoic acid induces matrix Gla protein gene expression in human bone cells. Endocrinology. 1992;130:102-108.
9. Rice JS, Williamson MK, Price PA. Isolation and sequence of the vitamin K-dependent matrix Gla protein from the calcified cartilage of the soupfin shark. J Bone Min Res. 1994;9:567-576.
10. Hale JE, Williamson MK, Price PA. Carboxyl-terminal proteolytic processing of matrix Gla protein. J Biol Chem. 1991;266:21145-21149.
11. Price PA, Rice JS, Williamson MK. Conserved phosphorylation of serines in the Ser-X-Glu/Ser(P) sequences of the vitamin K-dependent matrix Gla protein from shark, lamb, rat, cow, and human. Protein Sci. 1994;3:822-830.
12. Munroe PB, Olgunturk RO, Fryns JP, Van Maldergren L, Ziereisen F, Yuksel B, Gardiner RM, Chung E. Mutations in the gene encoding the human matrix Gla protein cause Keutel syndrome. Nat Genet. 1999;21: 142-144.
13. Keutel J, Jorgensen G, Gabriel P. A new autosomal recessive syndrome: peripheral pulmonary stenoses, brachytelephalangism, neural hearing loss, and abnormal cartilage calcifications/ossification. Birth Defects Orig Artic Ser. 1972;8:60-68.
14. Teebi AS, Lambert DM, Kaye GM, Al-Fifi S, Tewfik TL, Azouz EM. Keutel syndrome: further characterization and review. Am J Med Genet. 1998;77:182-187.
15. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, Karsenty G. Spontaneous calcification of arteries and cartilage in mice lacking matrix Gla protein. Nature. 1997;386:78-81.
16. Price PA, Faus SA, Williamson MK. Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves. Arterioscler Thromb Vasc Biol. 1998;18:1400-1407.
17. Beadenkopf WG, Daoud AS, Love BM. Calcification in the coronary arteries and its relationship to atherosclerosis and myocardial infarction. Am J Roentgenol. 1964;7:865.
18. Eggen D, Strong JP, McGill HC. Coronary calcification: relationship to clinically significant coronary lesions and race, sex, and topographic distribution. Circulation. 1962;32:948-955.
19. Tanmura A, McGregor DH, Anderson HC. Calcification in atherosclerosis, 1: human studies. J Exp Pathol. 1986;2:261-273.
20. Dare AJ, Veinot JP, Edwards WD, Tazelaar HD, Schaff HV. New observations on the etiology of aortic valve disease: a surgical pathologic study of 236 cases from 1990. Hum Pathol. 1993;24:1330-1338.
21. Lindroos M, Kupari M, Valvanne J, Strandberg T, Heikkila J, Tilvis R. Factors associated with calcific aortic valve degeneration in the elderly. Eur Heart J. 1994;15:865-870.
22. Lippert JA, White CS, Mason AC, Plotnick GD. Calcification of aortic valve detected incidentally on CT scans: prevalence and clinical significance. Am J Roentgenol. 1995;164:73-77.
23. Otto CM, Kuusisto J, Reichenbach DD, Gown AM, O'Brien KD. Characterization of the early lesion of 'degenerative' valvular aortic stenosis: histological and immunohistochemical studies. Circulation. 1994;90: 844-853.
24. Gentile S, Bizzarro A, Marmo R, Bellis A, Orlando C. Medial arterial calcification and diabetic neuropathy. Acta Diabetol Lat. 1989;27: 243-253.
25. Monckeberg JG. Uber die reine Mediaverklekung der Extremitatenarterien und ihr Verhalten zur Arteriosklerose. Virchows Arch. 1903;171: 141-167.
26. Blankenhorn DH. The relation of age and sex to diffuse aortic calcification in man. J Gerontol. 1964;19:72-77.
27. Blumenthal HT, Lansing AI, Wheeler PA. Calcification of the media of the human aorta and its relation to intimal arteriosclerosis, ageing and disease. Am J Pathol. 1944;20:665-687.
28. Kanabrocki EL, Fels IG, Kaplan E. Calcium, cholesterol, and collagen levels in human aorta. J Gerontol. 1960;15:383-387.
29. Lansing AI, Rosenthal TB, Alex M, Dempsey EW. The structure and chemical characterization of elastin fibers as revealed by elastase and by electron microscopy. Anat Rec. 1952;114:555-575.
30. Elliott RJ, McGrath LT. Calcification of the human thoracic aorta during aging. Calcif Tissue Int. 1994;54:268-273.
31. Reid JD, Andersen ME. Medial calcification (whitlockite) in the aorta. Atherosclerosis. 1993;101:213-224.
32. 3. Mol Cell Biochem. 1991;107:169-183.
33. Takeo S, Anan M, Fujioka K, Kajihara T, Hiraga S, Miyake K, Tanonaka K, Minematsu R, Mori H, Taniguchi Y. Functional changes of aorta with massive accumulation of calcium. Atherosclerosis. 1989;77:175-181.
34. Kitagawa S, Yamaguchi Y, Kunitomo M, Imaizumi N, Fujiwara M. Altered vasoconstrictor responsiveness in vitamin D-induced arteriosclerotic rat aortas. Jpn J Pharmacol. 1993;61:283-289.
35. Kitagawa S, Yamaguchi Y, Kunitomo M, Imaizumi N, Fujiwara M. Impairment of endothelium-dependent relaxation in aorta from rats with arteriosclerosis induced by excess vitamin D and a high-cholesterol diet. Jpn J Pharmacol. 1992;59:339-347.
36. 3-induced calcific medial degeneration in coronary arteries of rats. J Cardiovasc Pharmacol. 1995;26: 207-213.
37. Bajwa GS, Morrison LM, Ershoff BH. Induction of aortic and coronary athero-arteriosclerosis in rats fed a hypervitaminosis D, cholesterol-containing diet. Proc Soc Exp Biol Med. 1971;138:975-982.
38. Otawara Y, Price PA. Developmental appearance of matrix Gla protein during calcification in the rat. J Biol Chem. 1986;261:10828-10832.
39. Chen PS, Toribara TY, Warner H. Microdetermination of phosphorus. Anal Chem. 1956;28:1756-1758.
40. Cancela ML, Williamson MK, Price PA. The putative RGD-dependent cell adhesion activity of matrix gla protein is due to higher molecular weight contaminants. J Biol Chem. 1994;269:12185-12189.
41. Cairns JR, Price PA. Direct demonstration that the vitamin K-dependent bone gla protein is incompletely carboxylated in humans. J Bone Miner Res. 1994;9:1989-1997.
42. Price PA, Kaneda Y. Vitamin K counteracts the effect of warfarin in liver but not in bone. Thrombosis. 1987;46:121-131.
43. Deleted in proof.
44. Fasco MJ, Cashin MJ. Effects of induction on R-and S-and metabolite concentrations in rat plasma. Toxicol Appl Pharmacol. 1980;56:101-109.
45. Shepherd AMM, Hewick DS, Moreland TA, Stevenson IA. Age as a determinant of sensitivity to warfarin. Br J Clin Pharmacol. 1977;4: 315-320.
46. Levy RJ, Schoen FJ, Levy JT, Nelson AC, Howard SL, Oshry RA. Biologic determinants of dystrophic calcification and osteocalcin deposition in glutaraldehyde-preserved porcine aortic valve leaflets implanted subcutaneously in rats. Am J Pathol. 1983;113:143-155.
47. Van Den Bos T, Oosting J, Everts V, Beertsen W. Mineralization of alkaline phosphatase-complexed collagen implants in the rat in relation to serum inorganic phosphate. J Bone Miner Res. 1995;10:616-624.
48. Coates T, Kirkland GS, Dymock RB, Murphy BF, Brealey JK, Mathew TH, Disney AP. Cutaneous necrosis from calcific uremic arteriolopathy. Am J Kidney Dis. 1998;32:384-391.
49. Drucke TB. A clinical approach to the uraemic patient with extraskeletal calcifications. Nephrol Dial Transplant. 1996;11:37-42.
50. Goldsmith DJA, Covic A, Sambrook PA, Ackrill P. Vascular calcification in long-term haemodialysis patients in a single unit: a retrospective analysis. Nephron. 1997;77:37-43.
51. Kerr DNS. Hypercalcemia and metastatic calcification. Cardiovasc Res. 1997;36:293-297.
52. Kingma JG, Roy PE. Ultrastructural study of hypervitaminosis D induced arterial calcification in Wistar rats. Artery. 1988;16:51-61.
53. 3 treatment of osteosarcoma cells. Calcif Tissue Int. 1990;46:270-279.